Global Novel Coronavirus (COVID-19) Vaccine Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028

2.1.2 Novel Coronavirus (COVID-19) Vaccine Market Size CAGR by Region

2.2 Novel Coronavirus (COVID-19) Vaccine Segment by Type

2.2.1 DNA

2.2.2 RNA

2.2.3 Others

2.3 Novel Coronavirus (COVID-19) Vaccine Market Size by Type

2.3.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

2.3.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type (2022-2028)

2.4 Novel Coronavirus (COVID-19) Vaccine Segment by Application

2.4.1 Mild Symptom Patient

2.4.2 Critically Ill Patient

2.5 Novel Coronavirus (COVID-19) Vaccine Market Size by Application

2.5.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

2.5.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Application (2022-2028)

3 Novel Coronavirus (COVID-19) Vaccine Key Players

3.1 Date of Key Players Enter into Novel Coronavirus (COVID-19) Vaccine

3.2 Key Players Novel Coronavirus (COVID-19) Vaccine Product Offered

3.3 Key Players Novel Coronavirus (COVID-19) Vaccine Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players Novel Coronavirus (COVID-19) Vaccine Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 Novel Coronavirus (COVID-19) Vaccine by Regions

4.1 Novel Coronavirus (COVID-19) Vaccine Market Size by Regions (2022-2028)

4.2 United States Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)

4.3 China Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)

4.4 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)

4.5 Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)

5 United States

5.1 United States Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)

5.2 United States Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)

6 China

6.1 China Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)

6.2 China Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)

7 Europe

7.1 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)

7.2 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)

8 Rest of World

8.1 Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)

8.2 Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Key Investors in Novel Coronavirus (COVID-19) Vaccine

10.1 Company A

10.1.1 Company A Company Details

10.1.2 Company Description

10.1.3 Companies Invested by Company A

10.1.4 Company A Key Development and Market Layout

10.2 Company B

10.2.1 Company B Company Details

10.2.2 Company Description

10.2.3 Companies Invested by Company B

10.2.4 Company B Key Development and Market Layout

10.3 Company C

10.3.1 Company C Company Details

10.3.2 Company Description

10.3.3 Companies Invested by Company C

10.3.4 Company C Key Development and Market Layout

10.4 Company D

10.5 ……

11 Key Players Analysis

11.1 Inovio Pharmaceuticals

11.1.1 Inovio Pharmaceuticals Company Details

11.1.2 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Offered

11.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.1.4 Inovio Pharmaceuticals Main Business Overview

11.1.5 Inovio Pharmaceuticals News

11.2 Takis Biotech (Evvivax)

11.2.1 Takis Biotech (Evvivax) Company Details

11.2.2 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Offered

11.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.2.4 Takis Biotech (Evvivax) Main Business Overview

11.2.5 Takis Biotech (Evvivax) News

11.3 Zydus Cadila

11.3.1 Zydus Cadila Company Details

11.3.2 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Offered

11.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.3.4 Zydus Cadila Main Business Overview

11.3.5 Zydus Cadila News

11.4 Codagenix, Inc.

11.4.1 Codagenix, Inc. Company Details

11.4.2 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offered

11.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.4.4 Codagenix, Inc. Main Business Overview

11.4.5 Codagenix, Inc. News

11.5 GeoVax, Inc.

11.5.1 GeoVax, Inc. Company Details

11.5.2 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offered

11.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.5.4 GeoVax, Inc. Main Business Overview

11.5.5 GeoVax, Inc. News

11.6 Bravovax

11.6.1 Bravovax Company Details

11.6.2 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Offered

11.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.6.4 Bravovax Main Business Overview

11.6.5 Bravovax News

11.7 Janssen Pharmaceutical Companies

11.7.1 Janssen Pharmaceutical Companies Company Details

11.7.2 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Offered

11.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.7.4 Janssen Pharmaceutical Companies Main Business Overview

11.7.5 Janssen Pharmaceutical Companies News

11.8 Altimmune

11.8.1 Altimmune Company Details

11.8.2 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Offered

11.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.8.4 Altimmune Main Business Overview

11.8.5 Altimmune News

11.9 Vaxart

11.9.1 Vaxart Company Details

11.9.2 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Offered

11.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.9.4 Vaxart Main Business Overview

11.9.5 Vaxart News

11.10 CanSino Biologics

11.10.1 CanSino Biologics Company Details

11.10.2 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Offered

11.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

11.10.4 CanSino Biologics Main Business Overview

11.10.5 CanSino Biologics News

11.11 ExpreS2ion Biotechnologies ApS

11.12 Clover Biopharmaceuticals

11.13 GSK

11.14 Vaxil Bio Ltd.

11.15 Generex

11.16 Novavax, Inc.

11.17 Sanofi Pasteur

11.18 Baylor

11.19 iBio, Inc.

11.20 Moderna, Inc.

11.21 Curevac

11.22 ImmunoPrecise

12 Research Findings and Conclusion

Table 1. Novel Coronavirus (COVID-19) Vaccine Market Size CAGR by Region (2022-2028) ($ Millions)

Table 2. Major Players of DNA

Table 3. Major Players of RNA

Table 4. Major Players of Others

Table 5. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

Table 7. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 8. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

Table 9. Date of Global Key Players Enter into Novel Coronavirus (COVID-19) Vaccine Market

Table 10. Global Key Players Novel Coronavirus (COVID-19) Vaccine Product Offered

Table 11. Key Players Novel Coronavirus (COVID-19) Vaccine Funding/Investment ($ Millions)

Table 12. Funding/Investment by Regions

Table 13. Funding/Investment by End Industry

Table 14. Key Players Novel Coronavirus (COVID-19) Vaccine Valuation & Market Capitalization ($ Millions)

Table 15. Key Players Mergers & Acquisitions, Expansion Plans

Table 16. Novel Coronavirus (COVID-19) Vaccine New Product/Technology Launches

Table 17. Novel Coronavirus (COVID-19) Vaccine Industry Partnerships, Agreements, and Collaborations

Table 18. Novel Coronavirus (COVID-19) Vaccine Industry Mergers and Acquisitions

Table 19. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Regions 2022-2028 ($ Millions)

Table 20. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Regions 2022-2028

Table 21. United States Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 22. United States Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

Table 23. United States Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 24. United States Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

Table 25. China Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 26. China Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

Table 27. China Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 28. China Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

Table 29. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 30. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

Table 31. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 32. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

Table 33. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 34. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

Table 35. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 36. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

Table 37. Key Market Drivers & Growth Opportunities of Novel Coronavirus (COVID-19) Vaccine

Table 38. Key Market Challenges & Risks of Novel Coronavirus (COVID-19) Vaccine

Table 39. Key Industry Trends of Novel Coronavirus (COVID-19) Vaccine

Table 40. Company A Company Details

Table 41. Companies Invested by Company A

Table 42. Company A Key Development and Market Layout

Table 43. Company B Company Details

Table 44. Companies Invested by Company B

Table 45. Company B Key Development and Market Layout

Table 46. Company C Company Details

Table 47. Companies Invested by Company C

Table 48. Company C Key Development and Market Layout

Table 49. Company C Company Details

Table 50. Companies Invested by Company C

Table 51. Company C Key Development and Market Layout

Table 52. Inovio Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 53. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 54. Takis Biotech (Evvivax) Basic Information, Head Office, Major Market Areas and Its Competitors

Table 55. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 56. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors

Table 57. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 58. Codagenix, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 59. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 60. GeoVax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 61. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 62. Bravovax Basic Information, Head Office, Major Market Areas and Its Competitors

Table 63. Bravovax Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 64. Janssen Pharmaceutical Companies Basic Information, Head Office, Major Market Areas and Its Competitors

Table 65. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 66. Altimmune Basic Information, Head Office, Major Market Areas and Its Competitors

Table 67. Altimmune Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 68. Vaxart Basic Information, Head Office, Major Market Areas and Its Competitors

Table 69. Vaxart Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 70. CanSino Biologics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 71. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 72. ExpreS2ion Biotechnologies ApS Basic Information, Head Office, Major Market Areas and Its Competitors

Table 73. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 74. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 75. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 76. GSK Basic Information, Head Office, Major Market Areas and Its Competitors

Table 77. GSK Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 78. Vaxil Bio Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 79. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 80. Generex Basic Information, Head Office, Major Market Areas and Its Competitors

Table 81. Generex Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 82. Novavax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 83. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 84. Sanofi Pasteur Basic Information, Head Office, Major Market Areas and Its Competitors

Table 85. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 86. Baylor Basic Information, Head Office, Major Market Areas and Its Competitors

Table 87. Baylor Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 88. iBio, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 89. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 90. Moderna, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 91. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 92. Curevac Basic Information, Head Office, Major Market Areas and Its Competitors

Table 93. Curevac Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

Table 94. ImmunoPrecise Basic Information, Head Office, Major Market Areas and Its Competitors

Table 95. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)

List of Figures

Figure 1. Picture of Novel Coronavirus (COVID-19) Vaccine

Figure 2. Novel Coronavirus (COVID-19) Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate 2022-2028 ($ Millions)

Figure 7. Novel Coronavirus (COVID-19) Vaccine Market Size by Region (2022 & 2027) ($ millions)

Figure 8. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)

Figure 9. Global DNA Market Size Growth Rate

Figure 10. Global RNA Market Size Growth Rate

Figure 11. Global Others Market Size Growth Rate

Figure 12. Novel Coronavirus (COVID-19) Vaccine in Mild Symptom Patient

Figure 13. Global Novel Coronavirus (COVID-19) Vaccine Market: Mild Symptom Patient (2022-2028) ($ Millions)

Figure 14. Novel Coronavirus (COVID-19) Vaccine in Critically Ill Patient

Figure 15. Global Novel Coronavirus (COVID-19) Vaccine Market: Critically Ill Patient (2022-2028) ($ Millions)

Figure 16. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)

Figure 17. Global Novel Coronavirus (COVID-19) Vaccine Market Size in Mild Symptom Patient Growth Rate

Figure 18. Global Novel Coronavirus (COVID-19) Vaccine Market Size in Critically Ill Patient Growth Rate

Figure 19. Funding/Investment

Figure 20. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Regions 2022-2028

Figure 21. United States Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)

Figure 22. China Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)

Figure 23. Europe Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)

Figure 24. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)

Figure 25. United States Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027

Figure 26. United States Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027

Figure 27. China Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027

Figure 28. China Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027

Figure 29. Europe Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027

Figure 30. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027

Figure 31. Rest of World Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027

Figure 32. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027